Daniel Braun

3.8k citations
22 papers · 3.0k · 3 hit papers · h-index 15

Impact in

  • Immunology top 1%
    • Psoriasis: Treatment and Pathogenesis
  • Dermatology top 0.5%
    • Dermatology and Skin Diseases

Papers in

    • Herpesvirus Infections and Treatments 5
    • Cytomegalovirus and herpesvirus research 4
    • Hepatitis B Virus Studies 2
    • Psoriasis: Treatment and Pathogenesis 6
    • Toxin Mechanisms and Immunotoxins 2

Daniel Braun

22 papers receiving 2.9k citations

Daniel Braun's Hit Papers

Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1 2016 · 439 citations
4390+3+7Years since publication200400600

Peers

Daniel Braun
Comparison fields: 5 of 92
  • Immunology 1.8k
  • Dermatology 564
  • Microbiology 34
  • Rheumatology 592
  • Hematology 264
Replace Shinichi Imafuku with:
Shinichi Imafuku Japan
Haifa H. Jabara United States
Kyriaki Dunussi‐Joannopoulos United States
Stefanie Kunz Germany
Hélène Moins‐Teisserenc France
Katrin Witte Germany
Melanie A. Kleinschek United States
Tomohiro Yoshimoto Japan
Christiane Pfeiffer Germany
B. H. Belohradsky Germany
Daniel Braun relative to Shinichi Imafuku Japan Shinichi Imafuku's profile →
Citations per field
00.5×10×17×
Shinichi Imafuku · 1×
Citations per year

Countries citing papers authored by Daniel Braun

Since Specialization
Citations

This map shows the geographic impact of Daniel Braun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Braun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Braun more than expected).

Fields of papers citing papers by Daniel Braun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Braun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Braun. The network helps show where Daniel Braun may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel Braun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel Braun Line = papers co-authored together Daniel Braun links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis
Hit paper breakdown →
2016666
2
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials
Hit paper breakdown →
2015664
3
Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1
Hit paper breakdown →
2016439
4 1997349
5 2014175
6 2010118
7 1983101
8 201698
9 201487
10 198484
11 199545
12 201744
13 199536
14 198432
15 199729
16 20217
17 20202
18 19972
19 20162
20 19951

About Daniel Braun

Daniel Braun is a scholar working on Epidemiology, Immunology, Infectious Diseases, Radiology, Nuclear Medicine and Imaging and Physiology, having authored 22 papers that have together received 3.0k indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (6 papers), Herpesvirus Infections and Treatments (5 papers), Cytomegalovirus and herpesvirus research (4 papers), Nitric Oxide and Endothelin Effects (2 papers), Toxin Mechanisms and Immunotoxins (2 papers), Hepatitis B Virus Studies (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Hepatitis C virus research (2 papers). The work is most often cited by research in Immunology (1.8k citations), Dermatology (564 citations), Microbiology (34 citations), Rheumatology (592 citations) and Hematology (264 citations). Daniel Braun has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Philip E. Pellett, G Dominguez, Gregory S. Cameron, J. Erickson, Kim Papp, Kristian Reich, Roberta J. Secrest, Olawale Osuntokun, Brian J. Nickoloff and Susan Ball. Their work appears in journals such as Journal of Virology, Journal of the American Academy of Dermatology, Clinical Microbiology Reviews, British Journal of Dermatology and Journal of Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact